Most Popular Stories
- UnitedHealth Group (UNH) Q3 Results - Q3 Top Health Insurance Company Earnings Report
- Engineer turns cell phone into low-cost microscope for quick field testing
- Illinois launches healthcare quality data site
- Senators ponder varied tax increases, including non-profit hospital tax
- Proposed cosmetic surgery tax is wrinkling a few brows
- WellPoint (WLP) Q3 Results - Q3 Top Health Insurance Company Earnings Report
Featured Jobs
-
Plastic Surgery Job in Colorado
StaffPointe, LLC - Denver, CO -
Internal Medicine Job in Georgia
StaffPointe, LLC - Savannah , GA -
Pulmonology Job in Missouri
StaffPointe, LLC - south central, MO -
Emergency Department Clinical Mgr Job in MD
StaffPointe, LLC - Baltimore, MD -
Peds Nurse Practitioner Job for Texas
StaffPointe, LLC - Houston, TX
Events
- Harvard Business School 7th Healthcare Conference
January 30, 2010 - Security Audits: Is Your Organization Prepared and In Compliance?
Dec.3 at 12 pm CT
Paid Research Reports
- Pricing and Reimbursement in Key Asia Pacific Markets
- Delivery Mechanisms for Large Molecule Drugs: Successes and failures of leading technologies and key drivers for market success
- The Cardiovascular Market Outlook to 2013: Competitive landscape, global market analysis and pipeline analysis
- Intellectual Property and Outsourcing in China: Minimizing risk whilst maximizing return on investment
- Health Care Equipment & Supplies: Global Industry Guide
- 2009 Trends to Watch: Healthcare Technology
FEATURES >> YouTube | Top acute-care hospitals | Women in Health IT | Top BlackBerry Apps | Commentary
TOPICS >> Stimulus | Health Reform | CMS News | Finance | EMRs | Mobile Healthcare | Hospital Leadership Blog
Free Newsletter
FierceHealthcare is the leading source of healthcare management news for healthcare industry executives. Join 46,000+ healthcare industry insiders who get FierceHealthcare via daily email. Sign up today!
Popular Topics
- Medicare
- health plans
- Centers for Medicare and Medicaid Services (CMS)
- Insurance
- Electronic Medical Records (EMRs)
- Food and Drug Administration (FDA)
- Department of Health and Human Services (HHS)
- Medicaid
- American Medical Association (AMA)
- healthcare system
- prescription drugs
- health reform
- pharmaceutical companies
FDA finds 20 drugs that could cause serious adverse reactions
The FDA has released its first quarterly report analyzing drugs for safety risks, concluding that at least 20 drugs have been found to cause serious adverse reactions. The report, the first of an ongoing series of quarterly publications, covers information on drug reactions voluntarily submitted by healthcare professionals from January through March of this year.
In the report, desflurane is cited as having the potential to cause cardiac arrest; tumor necrosis factor blockers are cited as carrying the risk of causing cancers in children and young adults; and heparin as having the potential for anaphylactic-type reactions. Oxycontin is mentioned because of the potential for misuse, abuse and overdose. The report also points out several other drugs that have confusing names, or labeling that could lead to overdoses and misuse, such as anti psychotic drug Seroquel, which it says can lead to overdose due to sample pack labeling confusion.
To learn more about the report:
- read this Modern Healthcare piece (reg. req.)
- read this FDA report
Related Articles:
FDA may urge training to dispense narcotics
CT Attorney General sues FDA over OxyContin
Off-label use of narcotic raises questions
Study: Accidental drug overdose rates hit new high
Related Stories
- DEA wants tough rules for e-prescribing controlled drugs
- Study: Accidental drug overdose rates hit new high
- Joint Commission issues new heparin rules
- Heart attack patients need their hearts started faster
- Questionable doctor continued to prescribe drugs illegally after conviction
- Study: Survival rates improve with more compressions during CPR
- Hospital heparin errors continue to be major problem
- SPOTLIGHT: Hospital investigating Baxter heparin deaths
- Senators urge end to fight over e-prescribing controlled substances
- Rapid-response teams have little effect on cardiac arrest deaths
Comments
Post new comment
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site Map | List in Marketplace | Supplier MarketplaceTHE FIERCEMARKETS NETWORKFierceFinance | FierceFinanceIT | FierceComplianceIT | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceMobileHealthcare | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceGovernmentIT | FierceBiotech | FierceBiotech Research | FiercePharma | FierceVaccines | FierceBiotechIT | FiercePharma Manufacturing | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceVoIP | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe© 2009 FierceMarkets, Inc. All rights reserved. |
![]() |





